Edesa Biotech Hires Peter Weiler From Exzell Pharma to be New CFO

, MT Newswires -  4:41 PM ET 4/4/2025 default

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print

04:41 PM EDT, 04/04/2025 (MT Newswires) -- Edesa Biotech ( EDSA ) said on Friday that it appointed Peter Weiler as chief financial officer at the immunotherapy company on May 1. Weiler will replace Stephen Lemieux, who is leaving to pursue other opportunities.

Weiler joins Edesa Biotech ( EDSA ) from privately held Exzell Pharma, where he was president since August 2018.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

© 1999-2025 Midnight Trader, Inc. All rights reserved.

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print
close
Please enter a valid e-mail address
Please enter a valid e-mail address
Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.
close

Your e-mail has been sent.